50242-214 : Xolair Pfs 75 mg/.5ml Subcutaneous Injection, Solution
NDC: | 50242-214 |
Labeler: | Genentech, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Xolair Pfs |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA103976 |
Rev. Date: |
NDC Package Codes:
- 50242-214-01: 1 SYRINGE, GLASS IN 1 CARTON (50242‑214‑01) > .5 ML IN 1 SYRINGE, GLASS
- 50242-214-03: 1 SYRINGE, GLASS IN 1 CARTON (50242‑214‑03) / .5 ML IN 1 SYRINGE, GLASS
- 50242-214-55: 1 SYRINGE, GLASS IN 1 CARTON (50242‑214‑55) / .5 ML IN 1 SYRINGE, GLASS
- 50242-214-83: 1 SYRINGE, GLASS IN 1 CARTON (50242‑214‑83) / .5 ML IN 1 SYRINGE, GLASS
- 50242-214-86: 1 SYRINGE, GLASS IN 1 CARTON (50242‑214‑86) > .5 ML IN 1 SYRINGE, GLASS
- 50242-214-99: 1 SYRINGE, GLASS IN 1 CARTON (50242‑214‑99) / .5 ML IN 1 SYRINGE, GLASS
Active Ingredients:
- Omalizumab
Dosage Strength:
- 75 mg/.5mL
Pharmaceutical Classes:
- Anti-IgE [EPC]
- Decreased IgE Activity [PE]
- IgE-directed Antibody Interactions [MoA]
Related Products:
Based on records with the same trade name.- 50242-215 Xolair Pfs 150 mg/ml Subcutaneous Injection, Solution by Genentech, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 50242-210Next: 50242-215 >
Related Discussions:
Xolair/Omalizumab-Hair Loss
I have been taking this medication for 5 month and I have experience a lot of hair loss. Spoke with a friend who is taki... 76 replies
I have been taking this medication for 5 month and I have experience a lot of hair loss. Spoke with a friend who is taki... 76 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.